Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 9, 2013, Pages 5225-5230

  Doroudchi, Mehrnoosh ^a,b,c   Pishe, Zahra Ghanaat ^c   Malekzadeh, Mahyar ^b,c   Golmoghaddam, Hossein ^a,c   Taghipour, Mousa ^a,c   Ghaderi, Abbas ^a,b,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glioma; IL 17A; IL 6; Meningioma; Schwannoma; Serum

Indexed keywords

IL17A PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 17; INTERLEUKIN 6; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; BLOOD; BRAIN TUMOR; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; FEMALE; GLIOMA; HUMAN; IMMUNOLOGY; MALE; MENINGIOMA; MIDDLE AGED; NEURILEMOMA; PRESCHOOL CHILD; TH1 CELL; TH2 CELL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; INTERLEUKIN-17; INTERLEUKIN-6; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEURILEMMOMA; TH1 CELLS; TH2 CELLS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84887605327     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.9.5225     Document Type: Article

References (48)

1. Alvarez-Rodríguez L, López-Hoyos M, Muñoz-Cacho P, Martínez-Taboada VM (2012). Aging is associated with circulating cytokine dysregulation. Cell Immunol, 273, 124-32.
2. Arima T, Natsume A, Hatano H, et al (2005). Intraventricular chordoid meningioma presenting with Castleman disease due to overproduction of interleukin-6. Case report. J Neurosurg, 102, 733-7.
3. Benchetrit F, Ciree A, Vives V, et al (2002). Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood, 99, 2114-21.
4. Bondy ML, Scheurer ME, Malmer B, et al (2008). Brain tumor epidemiology consortium. brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer, 113, 1953-68.
5. Damasceno M (2011). Bevacizumab for the first-line treatment of human epidermal growth factor receptor 2-negative advanced breast cancer. Curr Opin Oncol, 23, 3-9.
6. Doroudchi M, Saidi M, Malekzadeh M, et al (2013). Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status. Future Oncol, 992, 295-304.
7. Fong B, Barkhoudarian G, Pezeshkian P, et al (2011). The molecular biology and novel treatments of vestibular schwannomas. J Neurosurg, 115, 906-14.
8. Gridley DS, Loredo LN, Slater JD, et al (1998). Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. Cancer Detect Prev, 22, 20-9.
9. Gutierrez C, Schiff R (2011). HER2: biology, detection, and clinical implications. Arch Pathol Lab Med, 135, 55-62.
10. Hu J, Mao Y, Li M, Lu Y (2011). The profile of Th17 subset in glioma. Int Immunopharmacol, 11, 1173-9.
11. Jarnicki A, Putoczki T, Ernst M (2010). Stat3: linking inflammation to epithelial cancer-more than a "gut" feeling?. Cell Div, 5, 14.
12. Jiang Y, Uhrbom L (2012). On the origin of glioma. Ups J Med Sci, 117, 113-21.
13. Kantelhardt SR, Caarls W, de Vries AH, et al (2010). Specific visualization of glioma cells in living low-grade tumor tissue. PLoS One, 5, 11323.
14. Kryczek I, Wei S, Zou L, et al (2007). Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol, 178, 6730-3.
15. Kujas M (1993). Meningioma. Curr Opin Neurol, 6, 882-7.
16. Kumar R, Kamdar D, Madden L, et al (2006). Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients. Oncol Rep, 15, 1513-6.
17. Lee HK, Seo IA, Suh DJ, et al (2009). Interleukin-6 is required for the early induction of glial fibrillary acidic protein in Schwann cells during Wallerian degeneration. J Neurochem, 108, 776-86.
18. Louis DN, Ohgaki H, Wiestler OD, et al (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 114, 97-109.
19. MacKenzie DJ (1926). A classification of the tumours of the glioma group on a histogenetic basis with a correlated study of prognosis. Can Med Assoc J, 16, 872.
20. Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancer-related inflammation. Nature, 454, 436-44.
21. Martin-Orozco N, Muranski P, Chung Y, et al (2009). T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity, 31, 787-98.
22. Martin-Villalba A, Okuducu AF, von Deimling A (2008). The evolution of our understanding on glioma. Brain Pathol, 18, 455-63.
23. Merlo A, Juretic A, Zuber M, et al (1993). Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns. Eur J Cancer, 29, 2118-25.
24. Michaud DS, Gallo V, Schlehofer B, et al (2010). Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev, 19, 2562-9.
25. Minniti G, Amichetti M, Enrici RM (2009). Radiotherapy and radiosurgery for benign skull base meningiomas. Radiat Oncol, 4, 42.
26. Miyahara Y, Odunsi K, Chen W, et al (2008). Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA, 105, 15505-10.
27. Norden DA, Reardon AD, Wen YCP (2010). Primary central nervous system tumors: pathogenesis and therapy (Current Clinical Oncology). New York: Hummana: 2011 edition.
28. Numasaki M, Fukushi J, Ono M, et al (2003). Interleukin-17 promotes angiogenesis and tumor growth. Blood, 101, 2620-7.
29. Park KJ, Kang SH, Chae YS, et al (2010). Influence of interleukin-6 on the development of peritumoral brain edema in meningiomas. J Neurosurg, 112, 73-80.
30. Pfisterer WK, Hank NC, Preul MC, et al (2004). Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas. Neuro Oncol, 6, 290-9.
31. Pouratian N, Schiff D (2010). Management of low-grade glioma. Curr Neurol Neurosci Rep, 10, 224-31.
32. Rahaman SO, Harbor PC, Chernova O, et al (2002). Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.Oncogene, 21, 8404-13.
33. Reihmane D, Jurka A, Tretjakovs P, Dela F (2013). Increase in IL-6, TNF-a, and MMP-9, but not sICAM-1 concentrations depends on exercise duration. Eur J Appl Physiol, 113, 851-8.
34. Riemenschneider MJ, Jeuken JW, Wesseling P, Reifenberger G (2010). Molecular diagnostics of gliomas: state of the art. Acta Neuropathol, 120, 567-84.
35. Rittierodt M, Tschernig T, Samii M, et al (2001). Evidence of recurrent atypical meningioma with rhabdoid transformation and expression of pyrogenic cytokines in a child presenting with a marked acute-phase response: case report and review of the literature. J Neuroimmunol, 120, 129-37.
36. Sato T, Sugiyama T, Kawataki T, et al (2010). Clear cell meningioma causing Castleman syndrome in a child. J Neurosurg Pediatr, 5, 622-5.
37. Sfanos KS, Bruno TC, Maris CH, et al (2008). Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res, 14, 3254-61.
38. Sherry MM, Reeves A, Wu JK, Cochran BH (2009). STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells, 27, 2383-92.
39. Sim M, Dawson B, Landers G, et al (2013). Effect of exercise modality and intensity on post-exercise interleukin-6 and hepcidin levels. Int J Sport Nutr Exerc Metab, 23, 178-86.
40. Sreekanthreddy P, Srinivasan H, Kumar DM, et al (2010). Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis. Cancer Epidemiol Biomarkers Prev, 19, 1409-22.
41. Tofaris GK, Patterson PH, Jessen KR, Mirsky R (2002). Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci, 22, 6696-703.
42. Van Meir E, Sawamura Y, Diserens AC, et al (1990). Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res, 50, 6683-8.
43. Wang L, Yi T, Kortylewski M, et al (2009). IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med, 206, 1457-64.
44. Wernicke AG, Dicker AP, Whiton M, et al (2010). Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma. Radiat Oncol, 5, 46.
45. Wiemels J, Wrensch M, Claus EB (2010). Epidemiology and etiology of meningioma. J Neurooncol, 99, 307-14.
46. Zhang B, Rong G, Wei H, et al (2008). The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun, 374, 533-7.
47. Zhang Y, Yu J, Qu L, Li Y (2012). Calcification of vestibular schwannoma: a case report and literature review. World J Surg Oncol, 10, 207.
48. Zhou J, Tryggestad E, Wen Z, et al (2011). Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med, 17, 130-4.